Close

Intercept Pharm (ICPT) Reports Q4 Loss of $2.02

March 18, 2013 4:45 PM EDT
Intercept Pharm (NASDAQ: ICPT) reported Q4 EPS of ($2.02), versus ($1.32) reported last year.

For earnings history and earnings-related data on Intercept Pharm (ICPT) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings